# Teriparatide vs risedronate: VERO fracture trial results

Source: https://pepvault.app/research/teriparatide-vero-2018

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Teriparatide](https://pepvault.app/research#teriparatide)

Randomized trial · people

# Teriparatide: fewer new vertebral fractures than risedronate in VERO

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In this head-to-head trial, teriparatide led to fewer new spine and clinical fractures than risedronate over 24 months in severe post-menopausal osteoporosis, while the difference in non-vertebral fractures was not significant.

- **Kind:** Randomized trial
- **Studied in:** People
- **Published:** 2018
- **Journal:** Lancet

## What they tested

The team tested whether teriparatide prevents new fractures better than risedronate in women with severe osteoporosis after menopause.

## How the study was done

A double-blind, double-dummy randomized controlled trial at many centers. Each group had 680 post-menopausal women who already had vertebral (spine) fractures and low bone density. One group got daily teriparatide 20 μg shots plus a weekly dummy pill. The other got weekly risedronate 35 mg pills plus daily dummy shots, for 24 months.

<!--promo-->

PepVault for iPhone

## Taking teriparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

After 24 months, a new spine fracture showed up on X-ray in 28 (5.4%) of 680 women on teriparatide and in 64 (12.0%) of 680 on risedronate, a risk ratio of 0.44. Clinical fractures, meaning non-vertebral fractures plus spine fractures that caused symptoms, were also less common with teriparatide: 30 (4.8%) vs 61 (9.8%), a hazard ratio of 0.48. Non-vertebral fragility fractures happened in 25 (4.0%) women on teriparatide and 38 (6.1%) on risedronate, but this gap was not statistically significant (p=0.10).

## What it doesn’t show

Only post-menopausal women with severe osteoporosis and existing spine fractures took part, so the results may not apply to milder cases or to men. The study was funded by Lilly.

## The paper

Kendler et al. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet. 2018.

- [PubMed (PMID 29129436)](https://pubmed.ncbi.nlm.nih.gov/29129436/)
- [The paper (DOI 10.1016/S0140-6736(17)32137-2)](https://doi.org/10.1016/S0140-6736%2817%2932137-2)
- [ClinicalTrials.gov (NCT01709110)](https://clinicaltrials.gov/study/NCT01709110)

## The compound

- [Teriparatide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

## With this study

### Teriparatide

- [Teriparatide: the full reference](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)](https://pepvault.app/research/teriparatide-li-2024)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [All 10 studies](https://pepvault.app/research#teriparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Randomized controlled trial (RCT)](https://pepvault.app/glossary/randomized-controlled-trial)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)

## More studies on Teriparatide

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025) Meta-analysis · people · 2025
- [Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)](https://pepvault.app/research/teriparatide-li-2024) Meta-analysis · people · 2024
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023) Meta-analysis · people · 2023
- [Teriparatide: more bony union at 6 months than zoledronate after PLIF](https://pepvault.app/research/teriparatide-xiong-2022) Randomized trial · people · 2022
- [Teriparatide: 45.4% of jaw osteonecrosis lesions resolved by 52 weeks](https://pepvault.app/research/teriparatide-sim-2020) Randomized trial · people · 2020
- [Teriparatide then denosumab: spine density up 18.3% over 4 years](https://pepvault.app/research/teriparatide-data-switch-2015) Randomized trial · people · 2015
- [Every study on Teriparatide](https://pepvault.app/research#teriparatide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking teriparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking teriparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Teriparatide

- [Teriparatide: the full reference](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)](https://pepvault.app/research/teriparatide-li-2024)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [All 10 studies](https://pepvault.app/research#teriparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Randomized controlled trial (RCT)](https://pepvault.app/glossary/randomized-controlled-trial)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)

<!--promo-->

PepVault for iPhone

## Taking teriparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Teriparatide](https://pepvault.app/research#teriparatide)

## The library

- [Teriparatide](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
